Bankruptcy: Gritstone bio, Inc.
Form Type: 15-12G
Filing Date: 2025-04-04
Corporate Action: Bankruptcy
Type: New
Accession Number: 000119312525073407
Filing Summary: On April 4, 2025, Gritstone bio, Inc. filed a Form 15-12G to certify the termination of its registration under Section 12(g) of the Securities Exchange Act of 1934. This follows the company's petition for relief under Chapter 11 filed in October 2024. The document announces that on April 3, 2025, the Bankruptcy Court confirmed a Second Modified Plan of Reorganization, which became effective on April 4, 2025. As part of this reorganization plan, all outstanding shares of the company’s common stock have been cancelled and discharged, indicating a complete dissolution of shareholder equity as a result of the bankruptcy proceedings.
Document Link: View Document
Additional details:
Rule Provisions Used: Rule 12g-4(a)(1)
Approximate Number Of Holders: 0
Effective Date: 2025-04-04
Plan Confirmation Date: 2025-04-03
Petition Filed Date: 2024-10-10
Form Type: 8-K
Filing Date: 2025-04-04
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525073396
Filing Summary: On April 3, 2025, Gritstone bio, Inc. received a court order confirming its Second Modified Plan of Reorganization following a voluntary petition for relief filed under Chapter 11. The Plan became effective on April 4, 2025, leading to the cancellation and discharge of all outstanding shares of common stock, equity awards, and other rights to acquire common stock. Holders of subordinated claims will receive no distributions. The reorganization will allow the company to emerge from bankruptcy with a restructured balance sheet, converting part of the debt into new equity. A Liquidating Trust will be established for the benefit of general unsecured creditors, and significant changes were made in management as directors resigned upon the Plan's effectiveness.
Document Link: View Document
Additional details:
Item 1 03: Confirmed bankruptcy and reorganization plan
Item 3 02: Issued New Equity Interests
Item 5 01: Change in control due to bankruptcy restructuring
Item 5 02: Resignation of company directors
Item 8 01: Deregistration of securities and suspension of reporting obligations
Form Type: POS AM
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067078
Filing Summary: Gritstone bio, Inc. filed a Post-Effective Amendment No. 1 to Form S-3 Registration Statement with the SEC on March 28, 2025. This filing relates to multiple registration statements previously filed by the company. Due to a Chapter 11 bankruptcy proceeding initiated on October 10, the Company is removing from registration all unsold securities previously authorized by these statements. This decision aligns with the approval of the First Modified Plan of Reorganization, with the expectation that confirmation orders will be entered by the Bankruptcy Court. The document marks the termination of the effectiveness of the Registration Statements, reflecting a significant shift in the company’s corporate status and offerings as it navigates bankruptcy proceedings and business restructuring.
Document Link: View Document
Additional details:
Registration Number: 333-276242
Registration Number: 333-268524
Registration Number: 333-263455
Registration Number: 333-260292
Company Address: 5959 Horton Street, Suite 300 Emeryville, California 94608
Agent Name: Vassiliki Economides
Agent Title: Interim Chief Executive Officer and Chief Financial Officer
Form Type: POS AM
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067085
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed a Post-Effective Amendment No. 1 to its Registration Statements related to several Form S-3 registrations. The filing is part of a deregistration process for securities that were not sold, which is occurring due to the company's Chapter 11 bankruptcy proceedings initiated on October 10, 2023. The company has terminated all offerings of its securities as per the Plan of Reorganization expected to be confirmed by the Bankruptcy Court. This amendment highlights the removal from registration of unsold securities and updates the status of the previous registration statements affected by this bankruptcy.
Document Link: View Document
Additional details:
Registration Statement Number: 333-276242
Registration Statement Number: 333-268524
Registration Statement Number: 333-263455
Registration Statement Number: 333-260292
Voluntary Petition Date: 2023-10-10
Form Type: POS AM
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067090
Filing Summary: Gritstone bio, Inc. has filed a Post-Effective Amendment to deregister securities associated with four Registration Statements on Form S-3. This action follows the company's voluntary petition for relief under Chapter 11, initiated on October 10, 2023, in the United States Bankruptcy Court for the District of Delaware. The registration statements being amended include: No. 333-276242 effective as of December 29, 2023; No. 333-268524 effective as of December 1, 2022; No. 333-263455 effective as of May 6, 2022; and No. 333-260292, effective as of October 29, 2021. The deregistration reflects that none of the securities registered remain unsold as a result of the Chapter 11 proceedings. The company expects the Bankruptcy Court to confirm the First Modified Plan of Reorganization, with an effective date pending satisfaction of all conditions. By filing these amendments, Gritstone bio, Inc. terminates the effectiveness of its previous Registration Statements.
Document Link: View Document
Additional details:
Registration Statement No: 333-276242
Registration Statement No: 333-268524
Registration Statement No: 333-263455
Registration Statement No: 333-260292
Form Type: POS AM
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067102
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed a Post-Effective Amendment to its registration statements on Form S-3. The amendments deregister all securities that were previously registered but unsold under these statements due to the company's ongoing Chapter 11 bankruptcy proceedings. A voluntary petition for relief under Chapter 11 was filed on October 10, 2023. The company is in the process of implementing a reorganization plan, with an expected confirmation order from the Bankruptcy Court. This amendment reflects the termination of all security offerings and the deregistration of the company's previously registered securities. The effective date of the reorganization plan will occur once all prior conditions are satisfied.
Document Link: View Document
Additional details:
Registration Number: 333-276242
Registration Number: 333-268524
Registration Number: 333-263455
Registration Number: 333-260292
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067111
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed Post-Effective Amendments to several Form S-8 Registration Statements with the SEC, following their Chapter 11 bankruptcy petition filed on October 10, 2024. The amendments indicate that due to the ongoing bankruptcy proceedings, the company has terminated all offerings of its common stock as per the Registration Statements. The company has deregistered all shares of common stock that were registered but unsold under the Registration Statements. The amendments also serve to revoke the effectiveness of the original Registration Statements to reflect these changes. Gritstone bio continues as a non-accelerated filer and smaller reporting company under SEC definitions. The amendments were signed off by Vassiliki Economides, the Interim CEO and CFO of Gritstone bio, Inc.
Document Link: View Document
Additional details:
Registration Statement No: 333-277670
Registration Statement No: 333-270429
Registration Statement No: 333-264804
Registration Statement No: 333-263451
Registration Statement No: 333-255847
Registration Statement No: 333-254177
Registration Statement No: 333-237095
Registration Statement No: 333-230581
Registration Statement No: 333-227665
Address Of Principal Executive Offices: 5959 Horton Street, Suite 300 Emeryville, California 94608
Name Of Agent For Service: Vassiliki Economides
Telephone Number Of Agent For Service: (510) 871-6100
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067119
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements. This action is linked to the company’s prior Chapter 11 bankruptcy filing on October 10, 2024, in the United States Bankruptcy Court for the District of Delaware. As part of the proceedings under the Bankruptcy Code, the company terminated all offerings of its common stock previously registered under the S-8 Registration Statements. The company is in the process of having its First Modified Plan of Reorganization confirmed by the Bankruptcy Court, and these amendments effectively remove from registration any shares of common stock that remain unsold as of the date of this filing. The amendments are intended to reflect the deregistration of shares as required due to the ongoing bankruptcy situation.
Document Link: View Document
Additional details:
Form Type: S-8 POS
Registration Statements: [{"registration_no":"333-277670","filed_date":"2024-03-05"},{"registration_no":"333-270429","filed_date":"2023-03-09"},{"registration_no":"333-264804","filed_date":"2022-05-09"},{"registration_no":"333-263451","filed_date":"2022-03-10"},{"registration_no":"333-255847","filed_date":"2021-05-06"},{"registration_no":"333-254177","filed_date":"2021-03-11"},{"registration_no":"333-237095","filed_date":"2020-03-11"},{"registration_no":"333-230581","filed_date":"2019-03-28"},{"registration_no":"333-227665","filed_date":"2018-10-02"}]
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067128
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed a Post-Effective Amendment to its Form S-8 registration statements with the SEC. This amendment relates to previous filings and signifies the company's response to its ongoing Chapter 11 bankruptcy proceedings initiated on October 10, 2024. The filing indicates that all offerings of the company’s common stock have been terminated as a result of the bankruptcy and that any unsold shares previously registered under the registration statements are being deregistered. The company is in the process of confirming a modified Plan of Reorganization, with expectations for an effective date once all conditions precedent to the Plan are satisfied. The filing reflects the company's compliance with the Securities Act of 1933 and a certification statement affirming meeting the requirements for filing on Form S-8.
Document Link: View Document
Additional details:
Registration Number: 333-277670
Registration Number: 333-270429
Registration Number: 333-264804
Registration Number: 333-263451
Registration Number: 333-255847
Registration Number: 333-254177
Registration Number: 333-237095
Registration Number: 333-230581
Registration Number: 333-227665
Agent Name: Vassiliki Economides
Agent Title: Interim Chief Executive Officer and Chief Financial Officer
Agent Address: 5959 Horton Street, Suite 300, Emeryville, California, 94608
Agent Phone: (510) 871-6100
Filing Date: 2025-03-28
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067133
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed Post-Effective Amendments to several Registration Statements on Form S-8 due to its Chapter 11 bankruptcy filing on October 10, 2024. The company is currently undergoing a reorganization plan and expects the Bankruptcy Court to confirm its First Modified Plan of Reorganization, at which point the effective date of the plan will commence. As a result of this filing, Gritstone bio, Inc. has terminated all offerings of its common stock as per the registration statements, effectively removing from registration all unsold shares. This action signifies the company's ongoing efforts to reorganize following its Chapter 11 proceedings.
Document Link: View Document
Additional details:
Registration Statement Number: 333-277670
Registration Statement Number: 333-270429
Registration Statement Number: 333-264804
Registration Statement Number: 333-263451
Registration Statement Number: 333-255847
Registration Statement Number: 333-254177
Registration Statement Number: 333-237095
Registration Statement Number: 333-230581
Registration Statement Number: 333-227665
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067139
Filing Summary: Gritstone bio, Inc. has filed Post-Effective Amendments to multiple Form S-8 Registration Statements due to a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on October 10, 2024. These amendments reflect the termination of all offerings of the Company's common stock pursuant to the Registration Statements, and the Company has deregistered all shares that were registered but unsold. The effective date of the Plan of Reorganization will occur once all conditions precedent are satisfied, and the Registration Statements are amended to indicate the deregistration of such common stocks. The document is signed by Vassiliki Economides, the Interim Chief Executive Officer and Chief Financial Officer, confirming compliance with the requirements for filing on Form S-8.
Document Link: View Document
Additional details:
Registration Statement: 333-277670
Registration Statement: 333-270429
Registration Statement: 333-264804
Registration Statement: 333-263451
Registration Statement: 333-255847
Registration Statement: 333-254177
Registration Statement: 333-237095
Registration Statement: 333-230581
Registration Statement: 333-227665
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067145
Filing Summary: Gritstone bio, Inc. filed Post-Effective Amendments to multiple Registration Statements on Form S-8. This is in response to a voluntary Chapter 11 bankruptcy petition filed on October 10, 2024, in the United States Bankruptcy Court for the District of Delaware. The amendments reflect the termination of all common stock offerings that were previously registered. Consequently, Gritstone bio, Inc. has removed from registration all shares that are registered but unsold under the affected Registration Statements and amended them to indicate this deregistration. The effective date for the Plan of Reorganization will be set once all conditions are met, following confirmation by the Bankruptcy Court.
Document Link: View Document
Additional details:
Registration Number: 333-277670
Registration Number: 333-270429
Registration Number: 333-264804
Registration Number: 333-263451
Registration Number: 333-255847
Registration Number: 333-254177
Registration Number: 333-237095
Registration Number: 333-230581
Registration Number: 333-227665
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067153
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed Post-Effective Amendments to its Form S-8 registration statements (Registration No. 333-277670, 333-270429, 333-264804, 333-263451, 333-255847, 333-254177, 333-237095, 333-230581, 333-227665) with the SEC. This filing follows a voluntary petition for relief under Chapter 11 of the Bankruptcy Code filed on October 10, 2024. The filing indicates that the Bankruptcy Court is expected to confirm the First Modified Plan of Reorganization, with the effective date contingent on the satisfaction of specific conditions. As part of the bankruptcy process, Gritstone bio, Inc. has terminated all offerings of common stock under the Registration Statements and has deregistered any unsold shares. The amendments also officially terminate the effectiveness of the Registration Statements as of this filing date.
Document Link: View Document
Additional details:
Registration Number: 333-277670
Registration Number: 333-270429
Registration Number: 333-264804
Registration Number: 333-263451
Registration Number: 333-255847
Registration Number: 333-254177
Registration Number: 333-237095
Registration Number: 333-230581
Registration Number: 333-227665
Address Of Principal Offices: 5959 Horton Street, Suite 300, Emeryville, California 94608
Company Officer Name: Vassiliki 'Celia' Economides
Company Officer Title: Interim Chief Executive Officer and Chief Financial Officer
Telephone Number: (510) 871-6100
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067159
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed a post-effective amendment to multiple Form S-8 Registration Statements with the SEC. This action follows the company's voluntary petition for relief under Chapter 11, filed on October 10, 2024, in the Delaware Bankruptcy Court. The company will terminate all offerings of its common stock as outlined in these Registration Statements. This amendment removes registration for any unsold shares under these Registration Statements and terminates their effectiveness. The expected Confirmation Order related to the First Modified Plan of Reorganization may lead to the effective date of the plan once all conditions are fulfilled.
Document Link: View Document
Additional details:
Registration Number: 333-277670
Registration Number: 333-270429
Registration Number: 333-264804
Registration Number: 333-263451
Registration Number: 333-255847
Registration Number: 333-254177
Registration Number: 333-237095
Registration Number: 333-230581
Registration Number: 333-227665
Address Of Principal Offices: 5959 Horton Street, Suite 300 Emeryville, California 94608
Name Of Agent: Vassiliki Economides
Title Of Agent: Interim Chief Executive Officer and Chief Financial Officer
Telephone Number: (510) 871-6100
Form Type: S-8 POS
Filing Date: 2025-03-28
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525067189
Filing Summary: On March 28, 2025, Gritstone bio, Inc. filed a Post-Effective Amendment to its Form S-8 Registration Statements. This amendment follows the company's voluntary petition for relief under Chapter 11 of the Bankruptcy Code on October 10, 2024. The company intends for the Bankruptcy Court to confirm its First Modified Plan of Reorganization, with the effective date of the Plan contingent on the satisfaction of all conditions precedent. Consequently, Gritstone bio has terminated all offerings of its common stock under previously filed Registration Statements, resulting in the removal of any registered but unsold shares from registration. The amendments signify the deregistration of these shares and terminate the effectiveness of the existing Registration Statements, which include multiple filings dating back to 2018. The document is signed by Vassiliki 'Celia' Economides, the Interim Chief Executive Officer and Chief Financial Officer of the company, affirming the filing's compliance with the requirements of the Securities Act of 1933.
Document Link: View Document
Additional details:
Registration Statement Number: 333-277670
Registration Statement Number: 333-270429
Registration Statement Number: 333-264804
Registration Statement Number: 333-263451
Registration Statement Number: 333-255847
Registration Statement Number: 333-254177
Registration Statement Number: 333-237095
Registration Statement Number: 333-230581
Registration Statement Number: 333-227665
Form Type: 8-K
Filing Date: 2025-02-25
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525035266
Filing Summary: On February 14, 2025, Gritstone bio, Inc. filed a monthly operating report (MOR) with the U.S. Bankruptcy Court for the District of Delaware as part of its ongoing Chapter 11 bankruptcy case, initiated on October 10, 2024. The MOR covers the financial performance and operations of the company for the period from December 1, 2024, to December 31, 2024. It is important to note that the MOR has not been reviewed or audited by independent accountants and is limited in scope, which may not provide a complete view of the company's financial situation. The registration mentions that trading in the company's common stock during the bankruptcy proceedings is highly speculative and poses significant risks, advising caution to investors. The filing includes cautionary statements about forward-looking statements, indicating inherent risks in the bankruptcy process and uncertainties regarding business results going forward.
Document Link: View Document
Additional details:
Title Of Class: Common Stock, $0.0001 par value per share
Trading Symbol: GRTSQ
Date Of Event Reported: 2025-02-14
Bankruptcy Case Number: Chapter 11 Case
Operating Report Covered Period: December 1, 2024 to December 31, 2024
Exhibit Number: 99.1
Exhibit Description: Gritstone bio, Inc. Monthly Operating Report for the period ended December 31, 2024.
Form Type: 8-K
Filing Date: 2025-02-14
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312525027252
Filing Summary: On January 14, 2025, Gritstone bio, Inc. filed a monthly operating report (MOR) related to its Chapter 11 bankruptcy case. The report covers the period from November 1, 2024, to November 30, 2024, and was submitted to the U.S. Bankruptcy Court for the District of Delaware. The filing follows the company's voluntary petition for relief under Chapter 11 that was submitted on October 10, 2024. The company cautions that the MOR is prepared solely for bankruptcy reporting requirements and has not been audited. The report was filed to comply with obligations under bankruptcy laws but should not be relied upon for investment decisions due to its limited scope and potential lack of completeness. The document also emphasizes that trading in Gritstone's common stock during the bankruptcy proceedings is highly speculative and carries substantial risks for investors.
Document Link: View Document
Additional details:
Monthly Operating Report: Gritstone bio, Inc. Monthly Operating Report for the period ended November 30, 2024.
Bankruptcy Case: Chapter 11 Case filed on October 10, 2024.
Trading Symbol: GRTSQ
Trading Status: Suspended from trading on Nasdaq and moved to OTC Pink Marketplace.
Form Type: 8-K
Filing Date: 2025-01-03
Corporate Action: Bankruptcy
Type: New
Accession Number: 000119312525001488
Filing Summary: Gritstone bio, Inc. filed for Chapter 11 bankruptcy on October 10, 2024. The Bankruptcy Court authorized an asset sale on December 23, 2024. On December 30, 2024, the company entered into an asset purchase agreement (APA) with Seattle Project Corp. for the sale of substantially all of its assets, except for certain excluded assets, for $21.25 million in cash. The asset sale was completed on December 30, 2024. Following the sale, several key executives resigned, with Vassiliki ‘Celia’ Economides appointed as the interim CEO and CFO. The company cautions shareholders about trading its stock during the bankruptcy proceedings, indicating that prices may not reflect the actual recovery for shareholders.
Document Link: View Document
Additional details:
Item 1 01: Asset Purchase Agreement
Item 1 03: Bankruptcy filing
Item 2 01: Completion of asset sale
Asset Sale Price: 21,250,000
Effective Date: 2024-12-31
Resigned Officers: ["Andrew Allen, M.D., Ph.D.","Matthew Hawryluk, Ph.D.","Erin E. Jones","Karin Jooss, Ph.D."]
New Officer: Vassiliki ‘Celia’ Economides
Role: interim CEO and CFO
Form Type: 8-K
Filing Date: 2024-12-13
Corporate Action: Bankruptcy
Type: Update
Accession Number: 000119312524278626
Filing Summary: On December 9, 2024, Gritstone bio, Inc. provided an update regarding its ongoing Chapter 11 bankruptcy proceedings initiated on October 10, 2024. The Company held an auction for its assets from December 9 to December 12, 2024. Hercules Capital, Inc., Future Solutions Investments LLC, and Seattle Project Corp. emerged as successful bidders for various assets, with total anticipated cash proceeds of approximately $21.25 million, pending Bankruptcy Court approval on December 20, 2024. The document emphasizes the speculative nature of trading in the Company’s Common Stock amidst the bankruptcy, noting potential risks and uncertainties.
Document Link: View Document
Additional details:
Successful Bidders: [{"bidder_name":"Hercules Capital, Inc.","assets_bid":"machinery and equipment"},{"bidder_name":"Future Solutions Investments LLC","assets_bid":"binder intellectual property"},{"bidder_name":"Seattle Project Corp.","assets_bid":"other assets"}]
Total Proceeds: 21.25 million USD
Secured Lender Credit Bids: {"hercules_capital":"3 million USD","future_solutions":"1.5 million USD"}
Court Approval Date: 2024-12-20
Comments
No comments yet. Be the first to comment!